Channel Avatar

CMT Research Foundation @UCAJm9ICMJ2HMhstqwvVSjow@youtube.com

290 subscribers - no pronouns :c

The CMT Research Foundation has one mission: to find treatme


01:41
The Greatest Gift: Jamal Hill
04:05
The Greatest Gift: Lily Sander
03:36
The Greatest Gift: Gary Berg
03:55
The Greatest Gift: Allison Taylor
02:48
The Greatest Gift: Rob Prior
38:40
You Are UNSTOPPABLE
12:27
Development of Gene Therapy for Rare Diseases
05:34
Clinical Development of CLC-1 Inhibitors For the Treatment of CMT
10:03
You and the Future of Clinical Trials in CMT
14:47
A Guide to Clinical Research: One Family's Journey
49:59
Fueling Progress With ENDGAME - The Campaign to End CMT1A
20:55
Lessons Learned From SOD1 ALS Clinical Development: Opportunities for CMT Drug Development
14:18
The State of Drug Development for CMT
04:56
Living With CMT
43:32
What is Happening to my Nerves and Body
04:58
Living With CMT
14:54
UNSTOPPABLE
14:09
Opening/Patients Taking Action
06:53
Patient Voices: How Your Scientific Progress Provides Hope
08:35
Patient Voices - Living With CMT
17:13
TRPV4 Inhibition in the Treatment of CMT2C
22:09
Supporting Translation of CMT1A Gene Therapy Through AAV-mediated Silencing of PMP22
17:09
Development of Gene Replacement Therapy for CMT4A Demyelinating Neuropathy
22:06
The Development of Tissue Tropic AAVs – Considerations Inside Out
11:59
Developing Lipid Nanoparticles for Non-Liver RNA Delivery
20:26
Current Status of Clinical Outcome Assessments and Biomarkers in CMT
44:36
Understanding the Criteria For Pursuing a Drug Program for CMT
20:08
Discovery of Small Molecules that Alter the Trafficking of PMP22 as A Potential Route
18:14
Developing Best-in-class HDAC6 Inhibitors for the Treatment of CMT1A
17:50
FDA Efforts to Advance Medical Product Development for Rare Diseases
17:16
Govorestat for CMT-SORD: Designing a Clinical Trial for a Slow Progressing CMT
20:39
Understanding Basic Biological Mechanisms to Identify Therapeutic Targets in CMT
20:50
Clinical Development of CLC- Inhibitor for the Treatment of Charcot-Marie-Tooth Disease
30:25
Beyond The Diagnosis: Patient Stories, Expert Insights. Episode 3
45:57
Beyond The Diagnosis: Patient Stories, Expert Insights. Episode 2
34:54
Beyond The Diagnosis: Patient Stories, Expert Insights. Episode 1
01:13:23
CMT1A Clinical Trial and Drug Development Update
03:44
Peter DeSilva - CMT Story
01:13:55
CMT1A Research Update: Looking Towards Clinical Trials and Treatments
00:23
The Greatest Gift: Bentzin $500,000 Match
00:29
The Greatest Gift: Eloise Schlafly
00:44
The Greatest Gift: Tara Haik
00:27
The Greatest Gift: Bentzin $500,000 Match
00:33
The Greatest Gift: Michelle Moon
00:34
The Greatest Gift: Lily Sander
01:21
The Bentzin Family: A $500,000 Match
53:20
Pushing Boundaries in CMT Research Early Stage Biotech Companies' Evolution and Insights on Therapy
44:52
Translating Academic Science to Business
59:16
Clinical Trial Readiness
26:59
The State of Gene Therapy in CMT
19:54
Models of CMT
01:20:18
Common Mechanisms of Disease
08:06
Challenges in Drug Development
19:30
Overview of the CMT Drug Development Pipeline
36:46
Patient Fireside Chat - Life with CMT
50:58
Keynote Address
36:35
Becoming Part of the Solution
01:01:38
Patient Powered Perspectives Biotech Insights on CMT and Collaborating with Patients
45:24
Understanding the Importance of Genetic Testing
29:10
Patient Voices